Skip to Main Content

Hello, everyone, and how are you this fine, sunny morning? The middle of the week has arrived, as you may know, so why not celebrate with a delicious cup of stimulation? After all, you made is this far, which is a likely sign of surviving another few days. And of course, no prescription is required, which is a good thing. And while you drink up, you can peruse some of the tidbits we have assembled to help you start the day. Hope you conquer the world and, as always, do keep in touch …

GlaxoSmithKline (GSK) and Pfizer (PFE) plan to combine their consumer health-care units and eventually spin off the joint venture, creating the world’s largest seller of drugstore staples like Advil and Sensodyne toothpaste, The Wall Street Journal writes. It’s an unexpected conclusion to a year-long process by Pfizer to shed its consumer business, as it and other pharmaceutical companies focus more on higher-margin prescription drugs. Glaxo has been pursuing the same focus, though has until now stayed committed to its consumer business.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!